The effects of polio eradication efforts on health systems: a cross-country analysis using the Develop-Distort Dilemma.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
03 Jun 2021
Historique:
received: 10 07 2020
revised: 12 01 2021
accepted: 23 03 2021
pubmed: 22 4 2021
medline: 29 7 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Vertical disease control programmes have enormous potential to benefit or weaken health systems, and it is critical to understand how programmes' design and implementation impact the health systems and communities in which they operate. We use the Develop-Distort Dilemma (DDD) framework to understand how the Global Polio Eradication Initiative (GPEI) distorted or developed local health systems. We include document review and 176 interviews with respondents at the global level and across seven focus countries (Afghanistan, Bangladesh, Democratic Republic of Congo, Ethiopia, India, Indonesia and Nigeria). We use DDD domains, contextual factors and transition planning to analyse interactions between the broader context, local health systems and the GPEI to identify changes. Our analysis confirms earlier research including improved health worker, laboratory and surveillance capacity, monitoring and accountability, and efforts to reach vulnerable populations, whereas distortions include shifting attention from routine health services and distorting local payment and incentives structures. New findings highlight how global-level governance structures evolved and affected national actors; issues of country ownership, including for data systems, where the polio programme is not indigenously financed; how expectations of success have affected implementation at programme and community level; and unresolved tensions around transition planning. The decoupling of polio eradication from routine immunization, in particular, plays an outsize role in these issues as it removed attention from system strengthening. In addition to drawing lessons from the GPEI experience for other efforts, we also reflect on the use of the DDD framework for assessing programmes and their system-level impacts. Future eradication efforts should be approached carefully, and new initiatives of any kind should leverage the existing health system while considering equity, inclusion and transition from the start.

Identifiants

pubmed: 33882118
pii: 6244781
doi: 10.1093/heapol/czab044
pmc: PMC8173659
doi:

Types de publication

Journal Article

Langues

eng

Pagination

707-719

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Références

Am J Public Health. 1997 Jun;87(6):922-5
pubmed: 9224170
Bull World Health Organ. 2002;80(10):822-8
pubmed: 12471404
BMC Public Health. 2020 Aug 12;20(Suppl 2):1176
pubmed: 32787949
BMC Health Serv Res. 2015 Jun 13;15:232
pubmed: 26071052
Health Policy Plan. 2012 Oct;27 Suppl 4:iv44-53
pubmed: 23014153
Front Public Health. 2018 May 07;6:136
pubmed: 29868544
Med Anthropol. 2012;31(5):385-403
pubmed: 22881380
Health Policy Plan. 2011 Jul;26 Suppl 1:i45-52
pubmed: 21729917
Lancet Infect Dis. 2013 Mar;13(3):183
pubmed: 23427880
Glob Public Health. 2020 Jul;15(7):956-967
pubmed: 32202468
Health Res Policy Syst. 2014 Aug 26;12:51
pubmed: 25160707
Health Policy Plan. 2017 Dec 1;32(10):1417-1426
pubmed: 29029075
Bull World Health Organ. 2016 Sep 1;94(9):705-708
pubmed: 27708476
Int J Health Policy Manag. 2015 Dec 12;5(3):201-4
pubmed: 26927593
Glob Public Health. 2009;4(6):546-60
pubmed: 19367477
BMC Health Serv Res. 2011 Dec 14;11:336
pubmed: 22168915
BMC Public Health. 2020 Aug 12;20(Suppl 2):1197
pubmed: 32787958
Health Aff (Millwood). 2013 Jul;32(7):1265-73
pubmed: 23836743
J Glob Health. 2020 Jun;10(1):010322
pubmed: 32274015
J Infect Dis. 2016 May 1;213 Suppl 3:S140-6
pubmed: 26908718
Am J Public Health. 1998 Jan;88(1):130-2
pubmed: 9584020
Hum Vaccin Immunother. 2012 Mar;8(3):293-301
pubmed: 22327490
J Infect Dis. 2014 Nov 1;210 Suppl 1:S504-13
pubmed: 24690667
Infect Dis Poverty. 2014 Oct 01;3(1):35
pubmed: 25320672
Health Policy Plan. 2012 Oct;27 Suppl 4:iv1-3
pubmed: 23014149
Health Policy Plan. 2012 Aug;27(5):365-73
pubmed: 21821667
J Epidemiol Community Health. 2007 Nov;61(11):933-7
pubmed: 17933949
Lancet. 2003 Sep 13;362(9387):909-14
pubmed: 13678981
Am J Public Health. 2002 Jan;92(1):19-23
pubmed: 11772750
Lancet. 2018 Sep 29;392(10153):1098-1099
pubmed: 30201272
PLoS Med. 2011 Aug;8(8):e1001073
pubmed: 21857809
Am J Public Health. 1997 Jun;87(6):913-6
pubmed: 9224167

Auteurs

Daniela C Rodriguez (DC)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, 8th Floor, Baltimore, MD 21205, USA.

Abigail H Neel (AH)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, 8th Floor, Baltimore, MD 21205, USA.

Yodi Mahendradhata (Y)

Center for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281, Indonesia.

Wakgari Deressa (W)

Department of Preventive Medicine, School of Public Health, Addis Ababa University, P. O. Box 9086, Addis Ababa, Ethiopia.

Eme Owoaje (E)

College of Medicine, University of Ibadan, AddL P.M.B 3017 G.P.O Ibadan, Nigeria.

Oluwaseun Akinyemi (O)

College of Medicine, University of Ibadan, AddL P.M.B 3017 G.P.O Ibadan, Nigeria.

Malabika Sarker (M)

BRAC James P Grant School of Public Health, BRAC University, 68 Shahid Tajuddin Ahmed Sharani, Mohakhali, Dhaka-1212, Bangladesh.
Heidelberg Institute of Global Health, Heidelberg University, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany.

Eric Mafuta (E)

Kinshasa School of Public Health, University of Kinshasa School of Public Health, Kinshasa, The Democratic Republic of Congo.

Shiv D Gupta (SD)

Indian Institute of Health Management Research, 1 Prabhu Dayal Marg, Near Sanganer Airport Terminal 1, Jaipur 302029, India.

Ahmad Shah Salehi (AS)

Global Innovation Consulting Services, Kabul, Afghanistan.

Anika Jain (A)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, 8th Floor, Baltimore, MD 21205, USA.

Olakunle Alonge (O)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, 8th Floor, Baltimore, MD 21205, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH